BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 17173042)

  • 1. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
    Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
    Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leading-edge research: PtdIns(3,4,5)P3 and directed migration.
    Franca-Koh J; Kamimura Y; Devreotes PN
    Nat Cell Biol; 2007 Jan; 9(1):15-7. PubMed ID: 17199126
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphoinositide lipid phosphatase SHIP1 and PTEN coordinate to regulate cell migration and adhesion.
    Mondal S; Subramanian KK; Sakai J; Bajrami B; Luo HR
    Mol Biol Cell; 2012 Apr; 23(7):1219-30. PubMed ID: 22323291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Src homology 2-containing inositol 5-phosphatase 1 (SHIP1) is involved in CD32a signaling in human neutrophils.
    Vaillancourt M; Levasseur S; Tremblay ML; Marois L; Rollet-Labelle E; Naccache PH
    Cell Signal; 2006 Nov; 18(11):2022-32. PubMed ID: 16682172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of FcgammaR-stimulated phagocytosis by the 72-kDa inositol polyphosphate 5-phosphatase: SHIP1, but not the 72-kDa 5-phosphatase, regulates complement receptor 3 mediated phagocytosis by differential recruitment of these 5-phosphatases to the phagocytic cup.
    Horan KA; Watanabe K; Kong AM; Bailey CG; Rasko JE; Sasaki T; Mitchell CA
    Blood; 2007 Dec; 110(13):4480-91. PubMed ID: 17682126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of PtdIns(3,4,5)P3/Akt signalling by inositol polyphosphate 5-phosphatases.
    Eramo MJ; Mitchell CA
    Biochem Soc Trans; 2016 Feb; 44(1):240-52. PubMed ID: 26862211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.
    An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X
    Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.
    Giuriato S; Pesesse X; Bodin S; Sasaki T; Viala C; Marion E; Penninger J; Schurmans S; Erneux C; Payrastre B
    Biochem J; 2003 Nov; 376(Pt 1):199-207. PubMed ID: 12885297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide phosphatases: just as important as the kinases.
    Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA
    Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of SHIP1 in macrophage programming and activation.
    Rauh MJ; Sly LM; Kalesnikoff J; Hughes MR; Cao LP; Lam V; Krystal G
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):785-8. PubMed ID: 15494015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors?
    Astle MV; Horan KA; Ooms LM; Mitchell CA
    Biochem Soc Symp; 2007; (74):161-81. PubMed ID: 17233589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts.
    Blero D; Zhang J; Pesesse X; Payrastre B; Dumont JE; Schurmans S; Erneux C
    FEBS J; 2005 May; 272(10):2512-22. PubMed ID: 15885100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of SHIP1 in T-lymphocyte life and death.
    Gloire G; Erneux C; Piette J
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):277-80. PubMed ID: 17371259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive visualization of the lipid product of class I PI3K in transgenic mouse models.
    Sasaki T; Sasaki J; Watanabe K; Suzuki A
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):215-8. PubMed ID: 17371241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
    Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
    Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Stabilized phosphatidylinositol 3,4,5-trisphosphate analogues bind Grp1 PH, inhibit phosphoinositide phosphatases, and block neutrophil migration.
    Zhang H; He J; Kutateladze TG; Sakai T; Sasaki T; Markadieu N; Erneux C; Prestwich GD
    Chembiochem; 2010 Feb; 11(3):388-95. PubMed ID: 20052709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How does SHIP1/2 balance PtdIns(3,4)P2 and does it signal independently of its phosphatase activity?
    Xie J; Erneux C; Pirson I
    Bioessays; 2013 Aug; 35(8):733-43. PubMed ID: 23650141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SH2-domain-containing inositol 5-phosphatase (SHIP) limits the motility of neutrophils and their recruitment to wounds in zebrafish.
    Lam PY; Yoo SK; Green JM; Huttenlocher A
    J Cell Sci; 2012 Nov; 125(Pt 21):4973-8. PubMed ID: 22946052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
    Pesesse X; Moreau C; Drayer AL; Woscholski R; Parker P; Erneux C
    FEBS Lett; 1998 Oct; 437(3):301-3. PubMed ID: 9824312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.